Metaoxedrin Minims Bausch + Lomb Ireland Limited (Phenylephrine Hydrochloride)

Phenylephrine hydrochloride selectively stimulates alpha‑1 adrenergic receptors on conjunctival blood vessels and the iris dilator muscle. This causes vasoconstriction, reducing redness, and contracts the dilator muscle, leading to pupil enlargement, which facilitates ocular assessment.

The dosing regimen for Metaoxedrin Minims is determined by the prescribing clinician. Typically, a single drop is instilled in the affected eye(s) as directed, and the frequency is adjusted based on the specific indication and patient response.

Safety data for phenylephrine ophthalmic use in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metaoxedrin Minims (phenylephrine) provides both vasoconstriction and mydriasis, whereas many alternatives such as naphazoline primarily offer vasoconstriction without pupil dilation. Phenylephrine’s dual action makes it useful when both redness relief and pupil enlargement are desired.

Store the ophthalmic solution at room temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from direct light, and retain it in the original packaging to avoid moisture exposure. Do not freeze the product.

Metaoxedrin Minims is applied topically to the eye. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place a single drop into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption.

Serious risks include a marked increase in intraocular pressure, especially in patients with narrow‑angle glaucoma, and systemic hypertension or cardiovascular events due to systemic absorption. Allergic reactions such as eyelid swelling or rash also require immediate medical attention.

Individuals with a known hypersensitivity to phenylephrine or any formulation excipients should avoid the product. It is also contraindicated in patients with narrow‑angle or acute angle‑closure glaucoma, and should be used with caution in those with uncontrolled cardiovascular disease.